Ibandronate to treat skeletal-related events and bone pain in metastatic bone disease or multiple myeloma: a meta-analysis of randomised clinical trials

OBJECTIVE: Randomised controlled trials (RCTs) have given contradictory results about the efficacy and safety of ibandronate in treating metastatic bone disease (MBD) or multiple myeloma. This review meta-analysed the literature to gain a more comprehensive picture. DESIGN: Systematic review and met...

Descripción completa

Detalles Bibliográficos
Autores principales: Geng, Chun-Jing, Liang, Qian, Zhong, Jian-Hong, Zhu, Min, Meng, Fan-Ying, Wu, Ning, Liang, Rui, Yuan, Bin-Yi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2015
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4458633/
https://www.ncbi.nlm.nih.gov/pubmed/26038356
http://dx.doi.org/10.1136/bmjopen-2014-007258

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4458633/
https://www.ncbi.nlm.nih.gov/pubmed/26038356
http://dx.doi.org/10.1136/bmjopen-2014-007258

Ejemplares similares